Quality of life 2
Quality of life 2
复制标题
生活质量2
作者：
S. Pham;J. Draugalis
1990年，美国的医疗保健支出达到6662亿美元，占国内生产总值的12.2%。据估计，到2000年，美国在医疗保健方面的开支将达到1.6万亿美元，相当于当年国内生产总值的16.4%。由于医疗保健费用的快速增长和可用资源的有限，患者/第三方支付者和政府已经启动并实施了更严格的成本控制措施。经济分析可以帮助确保在药物治疗等领域有效使用医疗保健资金。现有的四种方法是成本效益分析、成本效益分析、尽量减少成本分析和成本效用分析。本文综述了方法，并提供了医学文献中的例子。这些工具可以帮助护理提供者确定哪些治疗最具成本效益。
In 1990, health care expenditures in the United States reached $666.2 billion, 12.2% of the gross domestic product (GDP). It is projected for the year 2000, the USA will spend $1.6 trillion for health care which will be comparable to 16.4% of that year's GDP. As a result of the rapid increase in costs of health care and limited resources available, patients/third-party payers and the government have initiated and implemented more rigid cost control measures. Economic analyses can help ensure the efficient use of health care dollars in areas such as drug therapy. The four methodologies available are cost-benefit analysis, cost-effectiveness analysis, cost-minimization analysis and cost-utility analysis. This article reviews methods and provides examples from the medical literature. These tools can assist care providers in determining which treatments are most cost-effective.
米索前列醇预防非甾体抗炎药引起的胃肠道出血的成本效益。
DOI：
--
发表时间：
1990
期刊：
JAMA : the journal of the American Medical Association
影响因子：
--
作者：
Edelson,JT;Tosteson,AN;Sax,P
通讯作者：
Sax,P
疾病的免疫干预。
影响因子：
39.2
作者：
Fahey,JL;Sarna,G;Gale,RP;Seeger,R
通讯作者：
Seeger,R